Un equipo de investigación de las Universidades de Almería, Miguel Hernández de Alicante y Zaragoza, en colaboración con la fundación FISABIO, ha determinado las características de la proteína ...
Read moreThe Medical Physics research group of the Biosanitary Research Institute of Granada (ibs.GRANADA) has managed to develop a technology through photodiodes and phototransistors that allows the dose of r...
Read moreGlioblastoma is the most common and aggressive brain cancer, due to its ability to evade the immune system and grow. The Calcium cellular signalling research group at the Institute for Research in Bio...
Read morePembrolizumab, a monoclonal antibody which binds with the protein PD-1 to help immune cells destroy more cancer cells, is seeing a steady increase in its indications. Now, the KEYNOTE-048 phase III cl...
Read moreHeaded by ICREA researcher Dr. Manuel Serrano, scientists from the Cellular Plasticity and Disease lab at IRB Barcelona have managed to rejuvenate some mouse organs and tissues via cell reprogramming....
Read moreMutations in the BRCA1 gene are inherited from parents to children and carry a high risk of breast and ovarian cancer. One in 1,000 people are carriers of mutations in this gene, and between 45 and 85...
Read moreThey found that a simple blood test can help detect patients with resistance to brain radiotherapy and identified a drug that might reverse it. A multi-centre clinical study is now under way to valida...
Read moreA study performed by the European PEACE consortium, in which the Vall d’Hebron Institute of Oncology (VHIO), part of the Vall d’Hebron Campus, participated, has shown how adding abiraterone to and...
Read moreResearchers at Cima Universidad de Navarra have discovered new genetic pathways that cause the mutation of healthy cells and the tumor transformation in this type of lymphoma. This finding could contr...
Read moreHay una técnica que podría suplir esas carencias: la citrometría de flujo. Este método, ampliamente utilizado en el estudio de la sangre, está poco aprovechada en el análisis de los líquidos pl...
Read moreTools that currently help to identify which patients are more sensitive to this type of treatment have low specificity in advanced cancers. The Vall d’Hebron Institute of Oncology (VHIO) has develop...
Read moreDrs. Susana Rives, Montserrat Torrebadell and Nerea Vega (IRSJD) participate in a study led by Dr. Pablo Menéndez, group leader at the Josep Carreras Leukaemia Research Institut, who has identified a...
Read more